Post by Tiefenbacher Group

Affordable medicines are one of the most powerful tools for keeping healthcare systems sustainable. ♻️ 🌱 According to an IQVIA 2024 report, in Europe, affordable pharmaceuticals (so-called “generics”) account for around 70% of treatment volume while representing only 19% of medicine market value. This shows the real-world impact of affordable medicines: enabling more patients to be treated while reducing pressure on healthcare budgets. At Tiefenbacher Group, improving affordability of high-quality medicines is central to how we develop and expand our product portfolio. By combining scientific expertise with efficient supply chains, we strive to ensure that effective treatments remain accessible to healthcare systems and patients worldwide. 💙